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Abstract
Background—Bladder dysfunction in spina bifida (SB) patients can lead to significant 
morbidity due to renal insufficiency. Indications for surgery vary between institutions, and the 
impact is unclear. Our objective was to examine trends and variations in urologic interventions and 
chronic renal insufficiency in SB patients.
Methods—We reviewed the Nationwide Inpatient Sample (NIS) for all SB patients treated from 
1998–2011. We used ICD-9-CM codes to identify urologic surgery and chronic renal insufficiency 
(CRI). We calculated Spearman’s correlation coefficients between rates of SB-related bladder 
surgeries and rates of CRI outcomes by state. Linear regression models were fitted to investigate 
the associations between rates of SB-related surgery and CRI across treatment years.
Results—We identified 427,616 SB admissions (mean age 26y, 56% female); 35,249(8%) were 
for CRI and 11,078 (3%) were for surgery. Over the study period, CRI rates doubled (6–12%) and 
surgery rates declined (2.0–1.8%). There was a moderately weak, inverse association between 
surgery and CRI rates over time (r=−0.3, p=0.06) and by state (r=−0.3, p=0.04). On multivariate 
analysis, higher rates of surgery were associated with the state in which the patient was treated 
(p<0.001), younger age (p<0.001), and hospital teaching status (p<0.001). In contrast, CRI was 
not associated with SB-related surgery (p=0.67).
Conclusions—We observed a temporal and geographic trend toward decreasing urologic 
surgery and increasing CRI rates in SB and a wide variation in urologic surgical rates among 
states. Further study is needed to determine the factors behind these trends and variations in SB 
management.
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Spina bifida (SB) is a major congenital defect in which the neural tube fails to close properly 
during embryonic development and is the most common permanently disabling birth defect 
in the US.1, 2 Due to its involvement in multiple organ systems, managing children with SB 
presents many complex urologic challenges. Over 90% of affected individuals will have 
neurogenic bladder.3 Therefore, careful and attentive bladder management is paramount for 
the preservation of maximal renal function and achievement of the best-possible quality of 
life.4, 5
The approaches to bladder management include routine monitoring with imaging and 
urodynamic study, anti-cholinergic medications, clean intermittent catheterization, and 
various surgeries including, but not limited to, enterocystoplasty (bladder augmentation), 
bladder neck sling, sphincterotomy, urinary diversion (vesicostomy, ileal conduit), artificial 
urinary sphincter, botulinum toxin injection, and creation of catheterizable stomas 
(appendicovesicostomy, Monti channel). The indications for surgery vary significantly 
between institutions and providers, and the ideal strategy remains unclear.6
As an increasingly large number of children with SB are surviving beyond infancy into 
childhood and adolescence as a result of modern medical and surgical advances,7 evaluation 
of different bladder management approaches to achieve the best long-term outcomes is 
critical. It is known that high bladder storage pressures related to neurogenic bladder can 
lead to renal insufficiency, and bladder augmentation is not infrequently performed to reduce 
bladder pressure in order to protect the kidneys. Institutional series have shown rather low 
morbidity and mortality of various urologic surgical interventions in modern series.8–10 
However, the impact of those surgeries on long-term renal function is unclear. Little long-
term outcome data on bladder management strategies is available to help determine the best 
practices in terms of indication and timing of those procedures. On the other hand, the 
operative morbidity of bladder augmentation is well-described, including bladder stones, 
malignancy, or spontaneous perforation.11, 12 Some centers therefore have endorsed a less 
surgically-oriented approach for the management of neurogenic bladder among children and 
adults with SB 13 due to the advancement of new anti-cholinergic medications with fewer 
side effects, close monitoring with imaging and urodynamics, and increasing awareness of 
potential long-term complications of SB-related surgeries.12, 14
The objective of this study is to utilize national database to expand the perspectives on the 
variation of CRI and SB-related urologic surgery to gain insight on their relationship. We 
hypothesized that urologic surgery rates, specifically bladder augmentation, would be 
inversely related to CRI rates.
PATIENTS & METHODS
Data Source
The Nationwide Inpatient Sample (NIS) is an all-age, all-payer database managed by the 
Healthcare Cost and Utilization Project and sponsored by the Agency for Healthcare 
Research and Quality. Data in the NIS are from a 20% stratified probability sample of US 
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hospitals based on five hospital characteristics including ownership status, number of beds, 
teaching status, urban/rural location, and geographic region. NIS includes post-stratification 
discharge weights that may be used to calculate national estimates.15
Selection of Patients and Covariates
We identified all inpatient hospital encounters occurring between 1998 and 2011 for patients 
with an International Classification of Diseases, Ninth Revision, Clinical Modification 
(ICD-9-CM) diagnosis code for SB (741.X, 756.17).
Predictor variables were a priori selected based on biologic plausibility and/or demonstrated 
associations in the literature. Covariates included basic patient demographics: age, gender, 
race, insurance payer (public vs. private), ZIP code median household income (by quartiles), 
year of admission, as well as hospital level factors: hospital characteristics such as hospital 
teaching status (teaching, non-teaching), state, and hospital size according to number of beds 
(small, medium, and large).
Outcome Selection
The primary outcomes were SB-related urological surgery and CRI. We defined SB-related 
urological surgeries to include bladder augmentation, bladder neck sling, sphincterotomy, 
vesicostomy, artificial urinary sphincter, botulinum toxin injection, appendicovesicostomy, 
and urinary diversion. Surgeries were identified by ICD-9-CM procedure codes (Appendix 
1). CRI was defined based on ICD-9-CM codes (585 chronic kidney disease, 586 renal 
failure, unspecified) and/or Clinical Classifications Software codes (157, 158), and/or 
procedure codes for dialysis or renal transplant (58, 91, 105). Clinical Classifications 
Software codes are based on ICD-9-CM codes and were developed by AHRQ specifically 
for use in administrative data.16
Statistical Analysis
All analyses were weighted using NIS-specific estimated weights and covariance matrices. 
We calculated Spearman’s correlation coefficients to assess the relationship between rates of 
SB-related urological surgery in each state and rates of CRI outcomes in the same state. 
Linear regression models were fitted to investigate the associations between rates of SB-
related urological surgery and CRI over time.
Weighted logistic regression models were used to define the associations among patient and 
hospital level factors with SB-related urological surgery. Model covariates were a priori 
determined based on our conceptual model. The importance of each covariate was examined 
by comparing sequential nested models. We also conducted a sensitivity analysis examining 
the effects of these factors using generalized estimating equations (GEE) in order to control 
for clustering of similar patients in each hospital and each state.
All analyses were performed using SAS version 9.4 (SAS Institute Inc., Cary, NC). All tests 
were two-sided and p-values of 0.05 or less were considered to be significant.
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In total, we identified 427,616 SB admissions (Table 1) from 1998–2011 NIS. Females 
constituted 56% of the overall cohort. Mean patient age was 26 years old; the majority were 
adults (56%) followed by teenagers (13%). Socio-economic analysis revealed that 53% were 
Caucasians, 60% were publically insured, 37% were from the southern region of the United 
States, and most were treated in teaching (67%) and large (63%) hospitals.
SB-related urological surgery and Chronic renal insufficiency
Of the included SB admissions, 35,249 (8%) were identified with CRI, while 10,106 (2%) 
admissions were for SB-related urological surgery. Over the study period (1998–2011), 
admissions with CRI doubled (6–12%) and surgery rates declined slightly (2.0 to 1.8% in 
Figure 1). There was a moderately weak, inverse association between SB-related urological 
surgery and admissions with CRI over time (r=−0.3, p=0.06). Additionally, both SB-related 
urological surgery rates (range 0.4–6.2%) and admissions with CRI (range 3.4–19.3%) were 
highly variable among states (Figures 2, 3, & 4). A significant association was observed 
between states in surgery and admissions with CRI (r=−0.3, p=0.03).
Multivariable Analyses
The results of the bivariate and multivariate analyses are detailed in Table 2. On bivariate 
analysis, SB-related urologic surgery was associated with the particular state in which a 
patient was treated (p<0.001; each state not shown for sake of brevity), younger patient age 
(strongest in school age children, 6 to 11 years old; OR 8.7, p<0.001, private insurance (OR 
1.4, p<0.001), treatment at a teaching hospital (OR 3.9, p<0.001), and lower likelihood of 
admissions with CRI (OR 0.6, p<0.001).
On multivariate analysis, SB-related urologic surgery remained significantly associated with 
the particular state in which a patient was treated (p<0.001), younger patient age (again 
strongest among school age children, 6 to 11 years old; OR 6.5, p<0.001), and treatment at a 
teaching hospital (OR 2.7, p<0.001). On the other hand, admissions with CRI were not 
significantly associated with SB-related urologic surgery (OR 1.0, p=0.67). This was 
confirmed using GEE-based models to adjust for hospital- and state-level clustering 
(p=0.61).
DISCUSSION
To our knowledge, this study is the largest all-aged analysis investigating the association 
between CRI and SB-related surgery in SB patients on a population level. We found a trend 
towards a negative association between rates of admissions with CRI and SB-related surgery 
(r=−0.3, p=0.06): similarly, admissions with CRI doubled (6 to 12%) while surgery rates 
declined slightly (2.0 to 1.8%) from 1998 to 2011. This negative association was also 
observed across the states (r=−0.3, p=0.03). This result raises the concern that the pendulum 
of care may have swung too far towards conservative management and away from 
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performing the surgery to protect the upper tract in terms of bladder management in SB 
patients.
Interestingly, in our prior analysis using national pediatric inpatient data, we did not find 
similar negative association between CRI and bladder augmentation rate.17 This result may 
suggest the protective effect of SB-related surgery does not manifest until longer-term in 
older patients. With more SB patients surviving well into adulthood, developing best 
practices in terms of appropriate timing and indications for SB-related urologic surgery is 
essential to maintaining renal function and a better quality of life. Further research is 
warranted to investigate the longer-term impact of surgery on SB patients.
In addition, we observed significant variation in SB-related surgery rates across states (range 
from 0.4 to 6.2%); this is consistent with other prior studies.6, 18 Such variation has been 
observed in other clinical situations in which consensus is lacking on the best practices.19, 20 
Unwarranted variation is a reality within the medical care system and has been documented 
repeatedly using a wide range of data sources. Care pattern variation has also been 
demonstrated, in certain circumstances, to be associated with poorer clinical outcomes.21, 22 
In this case, it is particularly worrisome in the setting of the observed negative association 
between CRI and SB-related urologic surgery.
We also found that several patient- and hospital-level characteristics contributed to higher 
SB-related surgery rates, including teenage/school age patients and hospital teaching status. 
Urologic continence procedures are typically not performed until the child both expresses a 
serious desire for continence and proves attainment of a level of maturity necessary to assist 
in his or her own post-operative management, including clean intermittent catheterization. 
Very young patients are unlikely to achieve these criteria. On the other hand, older adult 
patients are most likely stable and/or content with their current conservative management or 
already had the SB-related surgery performed at earlier age. Not surprisingly, more 
procedures were performed in teaching hospitals due to the increased comorbidity level 
frequently found among SB patients.
These findings must be interpreted in the context of study limitations. NIS represents a 20% 
stratified sample of US hospital admissions. As such, our reported results may not be 
generalizable to encounters not in the sample pool such as those that occur in the outpatient 
setting. However, NIS does provide meticulous tracking of discharge and hospital weights in 
order to minimize the risk of sampling bias. Although we sampled records on 
hospitalizations at a national level, the possibility of sampling bias still exists. The NIS 
sampling frame has expanded over time, so earlier years may be more subject to sampling 
bias than later years; however, discharge and hospital weights have been developed to 
minimize this risk. We believe our model adequately accounts for both patient and hospital 
confounders but cannot rule out the risk of bias from omitted variables, as unmeasured 
covariates may account for some of the variation seen in outcomes such as surgical practice 
patterns.
Additionally, NIS is a large administrative database that might be affected by miscoding 
bias. Our analysis relies on the accuracy of the diagnostic and procedure codes included in 
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NIS; while the accuracy level of NIS is high for an administrative database, it is possible at 
least some portion of our cohort may be incorrectly coded. We were, therefore, deliberately 
broadly inclusive in our definition of chronic renal dysfunction, aiming to capture as much 
of this broad diagnosis as possible; however, coding alone cannot differentiate renal 
insufficiency due to nephrotoxic medications or sepsis versus neurogenic bladder. This type 
of coding could lead to either over- or under-estimation of the covariates such as CRI.
Because NIS represents admission-based rather than patient-based data, it is impossible to 
track a given patient across time. We were therefore unable to assess neither longer-term 
outcomes nor whether individual patients had multiple admissions. CRI patients may be 
readmitted much more than those without CRI and therefore may skew the observations. 
Additionally, the retrospective nature of this study limits the data that are available to us and 
makes it impossible to fully characterize causal relationships behind observed associations. 
For example, we had no data on patients’ medical or surgical history; therefore, we could not 
assess whether a patient with CRI had any prior SB-related surgery, nor could we evaluate 
the indication for the SB-related surgery at any given admission. We thus could not fully 
assess if the increasing CRI rate is a result from poor management or reflecting better 
longevity of spina bifida patients, nor could we drawn any conclusion that the variation and 
decreasing surgery rate were from provider’s preference or necessarily reflected the quality 
of SB management. However the temporal and geographic trend toward decreasing urologic 
surgery and increasing CRI rates are potentially concerning. A meticulously designed 
prospective study with long term follow up is warranted to help providers determine the best 
course of management for SB patient in the longer term.
CONCLUSION
We observed a significant temporal trend toward decreasing urologic surgery and increasing 
CRI rates, as well as a wide variation in urologic surgical rates in SB patients across states. 
Further study especially longitudinal data is needed to define the factors behind these trends 
and variations in urological SB management.
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Appendix 1. code dictionary
Procedures ICD-9 procedure codes ICD-9 diagnosis codes
bladder augment 57.87, 57.88
vesicostomy 57.21
sphincterotomy 57.91
conduit 56.51, 56.71, 56.72
Mitrofanoff V44.52
botox 99.29 596.54, 596.59, 788.30, 788.31, 788.32, 788.33, 625.6
Wang et al. Page 8














Per-year comparison of CRI rate (red line) and SB-related urologic surgery rate (blue line); 
this demonstrates an inverse association over time.
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CRI rate versus SB-related urologic surgery rate by state
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heat map for SB-related urologic surgery rate
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heat map for CRI rate
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Age (Mean±SD) 26.4±0.6 -
Age groups
 <1 y 42,801 10.0
 1 y 8,790 2.1
 2–5 y 24,846 5.8
 6–11 y 37,046 8.7
 12–18 y 53,708 12.6
 19–21 y 21,560 5.0
 >21 y 238,866 55.9
Gender
 male 188,236 44.0
 female 238,865 55.9
Race
 White 228,047 53.3
 Black 31,756 7.4
 Hispanic 52,212 12.2
 Asian 3,213 0.8
 Native American 2,090 0.5
 Others 10,112 2.4
Year
 1998 21,141 4.9
 1999 26,557 6.2
 2000 23,216 5.4
 2001 26,108 6.1
 2002 27,768 6.5
 2003 27,482 6.4
 2004 30,068 7.0
 2005 36,461 8.5
 2006 32,355 7.6
 2007 32,603 7.6
 2008 34,288 8.0
 2009 35,648 8.3
 2010 37,585 8.8
 2011 36,338 8.5
Insurance
 Public 254,798 59.6
 Private 145,482 34.0













Wang et al. Page 14
Characteristics n=427,616 %
 others 26,391 6.2
Income
 quartile 1 87,630 20.5
 quartile 2 80,503 18.8
 quartile 3 72,882 17.0
 quartile 4 54,204 12.7
Surgery
 augmentation 5,748 1.3
 vesicostomy 3,881 0.9
 sphincterotomy 76 <0.1
 conduit 1,173 0.3
 Mitrofanoff 1,015 0.2
 botox 1,105 0.3
Renal failure
 Yes 35,249 8.2
 No 392,368 91.8
Region
 Northeast 74,504 17.4
 Midwest 109,417 25.6
 South 160,079 37.4
 West 83,617 19.6
Hospital teaching status
 Non-teaching 139,913 32.7
 Teaching 284,839 66.6
Hospital bedsize
 Small 62,576 14.6
 Medium 94,012 22.0
 Large 268,164 62.7
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Table 2
Bivariate and multivariate analysis predicting use of SB-related urologic surgery
Covariates unadjusted OR (95%CI) p value adjusted OR (95%CI) p value
Age groups
 <1 y 0.6(0.4–0.8) <0.001 0.5(0.3–0.7) <0.001
 1 y 1.9(1.2–2.9) 0.06 1.4(0.9–2.2) 0.13
 2–5 y 4.3(3.4–5.5) <0.001 3.2(2.5–4.0) <0.001
 6–11 y 8.7(6.9–10.9) <0.001 6.5(5.1–8.2) <0.001
 12–18 y 6.9(5.7–8.5) <0.001 5.3(4.3–6.6) <0.001
 19–21 y 3.1(2.4–4.0) 0.16 2.7(2.1–3.5) <0.001
 >21 y ref
Gender
 male 1.0(0.9–1.1) 0.59 0.9(0.8–1.0) 0.05
 female ref
Year




 Private 1.4(1.2–1.6) <0.001 1.0(0.9–1.2) 0.70
Renal failure
 Yes 0.6(0.5–0.8) <0.001 1.0(0.8–1.3) 0.67
 No ref
Teaching status
 Yes 3.9(2.6–5.9) <0.001 2.7(1.9–3.7) <0.001
 No ref
*
State variable was not shown in the table for brevity
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